Lanthanide-Porphyrin Complexes As Anti-Tumor Agents
- Summary
- The Present Invention Relates To Lanthanide Porphyrin Complexes And Their Uses As Anti-Tumor Agents. The Described Complexes Show Promising Cytotoxic Properties Toward Cancer Cells In Both In Vitro And In Vivo Studies.
- Supplementary Information
- Patent Number: US20100069345A1
Application Number: US2006582062A
Inventor: Che, Chi-Ming | Wong, Suk-Yu
Priority Date: 19 Oct 2005
Priority Number: US20100069345A1
Application Date: 16 Oct 2006
Publication Date: 18 Mar 2010
IPC Current: A61K0031555 | A61P003500
US Class: 514184
Title: Lanthanide-porphyrin complexes as anti-tumor agents
Usefulness: Lanthanide-porphyrin complexes as anti-tumor agents
Summary: For the treatment of cancer, or for inhibiting tumor growth, where the tumor is cervical epitheloid carcinoma, human hepatocellular carcinoma, breast cancer, human coloadenocarcinoma or nasopharyngeal carcinoma, in human (claimed).
Novelty: Treating cancer e.g. cervical epitheloid carcinoma involves administering a pharmaceutical composition containing a lanthanide porphyrin complex to a patient
- Industry
- Disease Diagnostic/Treatment
- Sub Category
- Cancer/Tumor
- Application No.
- US2006582062A
- Country/Region
- Hong Kong
For more information, please click Here
